According to Fenix Leung, DPhil, GlobalData’s Analyst covering Oncology and Hematology, data from BMS’ Phase III trial, CheckMate-067, which compared the combination of the Opdivo (nivolumab) and Yervoy
They have also announced the addition of 100 snakes to the existing milking line to increase venom production for the upcoming international orders from India and China. "We
BIND is collaborating with AstraZeneca on the development of AZD2811, an Aurora B Kinase inhibitor that has been shown to be active in both solid and hematological tumors
Offering "Value through Innovation" as purveyors of prescription medication and consumer healthcare around the globe; Boehringer Ingelheim work in partnership with the world’s leading retailers to offer category
The FDA’s decision to approve the indication expansion was based on a placebo-controlled clinical phase III study (Study 332) of Fycompa in 164 patients aged 12 years and
ImMucin is an immunotherapeutic treatment which educates the MM patient’s immune system, particularly T-cells and antibodies, to attack MM cancer cells via a specific domain, termed signal peptide,
Commercial, medical and outcomes research teams in biopharma and life sciences companies will now be able to leverage an offering that combines IMS Health’s powerful Real-World Evidence (RWE)
As previously reported, oral treatment with Optina (low-dose danazol) has been shown to be safe and confer significant improvements in visual acuity (VA) and reductions in central retinal
The application covers InVivo’s investigational Neuro-Spinal Scaffold, which is currently being studied in a pilot clinical trial and has been successfully implanted in three patients. Also covered is
The trial enrolled patients across seven U.S. sites and is evaluating two constructs: a monovalent (gD) vaccine and a bivalent (gD + UL46) vaccine, each formulated with Vical’s
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.